Symbol: |
GBP2
|
Description: |
guanylate binding protein 2, interferon-inducible [Source:HGNC Symbol;Acc:4183]
|
Location: |
Chr1:89571815-89616139[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:141
Gene |
Compound |
Gen_sig |
Exp_pattern |
GBP2 |
Amquinate |
0.005 |
Down |
GBP2 |
NSC 37031 |
0.007 |
Down |
GBP2 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.014 |
Down |
GBP2 |
NSC 382006 |
0.032 |
Up |
GBP2 |
Maxima isoflavone D |
0.029 |
Down |
GBP2 |
MNQ |
0.048 |
Up |
GBP2 |
RAPAMYCIN PRODRUG |
0.025 |
Down |
GBP2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.02 |
Down |
GBP2 |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.037 |
Down |
GBP2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.015 |
Up |
GBP2 |
NSC 639211 |
0.037 |
Down |
GBP2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.042 |
Up |
GBP2 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.005 |
Down |
GBP2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.046 |
Down |
GBP2 |
NSC 651668 |
0.027 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:4
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|